Floatz logo

Immunoglobulin G1 (256-Tyrosine,258-Threonine,260-Glutamic Acid), Anti-(Neural Apoptosis-Regulated Proteinase 1) (Human-Mus Musculus Monoclonal Hrp00130 .Gamma.1-Chain), Disulfide With (3-Valine,5-Serine,49-Serine,66-Aspartic Acid) Human-Mus Musculus Monoclonal Hrp00130 .Kappa.-Chain, Dimer

Cerebral Atherosclerosis

Peking Union Medical College Hospitalmonoclonal_antibodyPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Cerebral Atherosclerosis cohort.

Asset / SponsorPhaseRating
Ferumoxytol
Northwestern University
Phase 4BB
Probucol
General Hospital of Shenyang Military Region
Phase 4BB
Rucacuzumab
Peking Union Medical College Hospital
Phase 4BB
Atorvastatin
General Hospital of Shenyang Military Region
Phase 4BB
Rosuvastatin
Samsung Medical Center
Phase 4BB

View all 12 →

Same molecule, other indications

Immunoglobulin G1 (256-Tyrosine,258-Threonine,260-Glutamic Acid), Anti-(Neural Apoptosis-Regulated Proteinase 1) (Human-Mus Musculus Monoclonal Hrp00130 .Gamma.1-Chain), Disulfide With (3-Valine,5-Serine,49-Serine,66-Aspartic Acid) Human-Mus Musculus Monoclonal Hrp00130 .Kappa.-Chain, Dimer is also rated in:

ischemic strokeActive
BB
Indicative · Phase 4
65 / 100
View asset →
atherosclerosisActive
BB
Indicative · Phase 4
65 / 100
View asset →
non-small cell lung carcinomaActive
B
Indicative · Phase 4
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →